Skip Navigation



Carcinogenesis Advance Access published online on August 19, 2004
Carcinogenesis, doi:10.1093/carcin/bgh254
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
25/12/2379    most recent
bgh254v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hirata, H.
Right arrow Articles by Hinoda, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirata, H.
Right arrow Articles by Hinoda, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received January 19, 2004
Revised July 13, 2004
Accepted August 2, 2004

MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma

Hiroshi Hirata 1, Naoko Okayama 2, Katsusuke Naito 1*, Ryo Inoue 1, Satoru Yoshihiro 1, Hideyasu Matsuyama 1, Yutaka Suehiro 2, Yuichiro Hamanaka 2, Yuji Hinoda 2

1 Department of Urology, Yamaguchi University School of Medicine, Yamaguchi, Japan
2 Department of Clinical Laboratory Science, Yamaguchi University School of Medicine, Yamaguchi, Japan

* To whom correspondence should be addressed. E-mail: katsunai{at}po.cc.yamaguchi-u.ac.jp.


  Abstract

It has been shown that the matrix metalloproteinase (MMP)-1 promoter polymorphism 1G/2G is associated with an increased risk of developing various cancers including renal cell carcinoma (RCC), and is in linkage disequilibrium (LD) with the MMP-3 promoter polymorphism 5A/6A. These two genes are localized in 11q22 adjacent to each other. However, the relationship between the MMP-3 5A/6A polymorphism and susceptibility to cancer remains ambiguous. In this study, we genotyped eight polymorphisms in the region containing the MMP-1 and MMP-3 genes in 177 healthy subjects, and explored the relationships between RCC and these polymorphisms or haplotypes in 156 RCC cases and 230 age- and gender-matched controls. All the subjects studied were of Japanese descent. There were three polymorphisms that showed stronger LD with the MMP-1 1G/2G promoter variant than with the MMP-3 5A/6A promoter variant. One of these three polymorphisms was present in exon 2 of the MMP-3 gene and caused an amino acid change, Glu45Lys (G/A). When the genotype distribution of Glu45Lys was compared between RCC patients and controls, the frequency of the G/G genotype was significantly higher in the patients (age- and gender-adjusted odds ratio [OR] = 1.81, 95% confidence interval [CI] = 1.20-2.74). A significant increase in the frequency of the 2G/2G genotype of the MMP-1 1G/2G polymorphism was also observed in the patients (age- and gender-adjusted OR = 1.86, CI = 1.23-2.82), whereas there was no significant difference for the MMP-3 5A/6A polymorphism. As expected based on these genotype-level results, the frequency of the 2G-G haplotype of MMP-1 1G/2G and MMP-3 Glu45Lys (G/A) polymorphisms was significantly higher in the patients than in the controls (crude OR = 1.95, CI = 1.31-2.91). These findings suggest that this haplotype of MMP-1 and MMP-3 variants may be associated with the risk of developing RCC.

Keywords: matrix metalloproteinase-1; matrix metalloproteinase-3; renal cell carcinoma; single nucleotide polymorphism; disease susceptibility; linkage disequilibrium.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 MutagenesisHome page
B. Peng, L. Cao, W. Wang, L. Xian, D. Jiang, J. Zhao, Z. Zhang, X. Wang, and L. Yu
Polymorphisms in the promoter regions of matrix metalloproteinases 1 and 3 and cancer risk: a meta-analysis of 50 case-control studies
Mutagenesis, October 20, 2009; (2009) gep041v1.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. Beeghly-Fadiel, Y.-B. Xiang, S. L. Deming, J.-R. Long, W.-H. Xu, Q. Cai, W. Zheng, and X. O. Shu
No Association between Matrix Metalloproteinase (MMP)-1, MMP-3, and MMP-7 SNPs and Endometrial Cancer Risk
Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1925 - 1928.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
J. M. Catania, G. Chen, and A. R. Parrish
Role of matrix metalloproteinases in renal pathophysiologies
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F905 - F911.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
A. Flex, E. Gaetani, A. S. Proia, G. Pecorini, G. Straface, F. Biscetti, G. Fioroni, A. Sabusco, R. Flore, P. Tondi, et al.
Analysis of functional polymorphisms of metalloproteinase genes in persons with vascular dementia and Alzheimer's disease.
J. Gerontol. A Biol. Sci. Med. Sci., October 1, 2006; 61(10): 1065 - 1069.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
N. Okayama, Y. Hamanaka, Y. Suehiro, Y. Hasui, J. Nakamura, and Y. Hinoda
Association of Interleukin-10 Promoter Single Nucleotide Polymorphisms -819 T/C and -592 A/C With Aging
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2005; 60(12): 1525 - 1529.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.